Eikon Therapeutics

Eikon Therapeutics is one of the...

• Unicorn.

Acquisition, funding and merger involving Eikon Therapeutics.

• Eikon Therapeutics has just announced a $106 Million fundraising (posted on June 6 2023).

View the org chart displaying its 22 main executives

Most searched biographies at Eikon Therapeutics

• Roger Perlmutter, Chief Executive Officer and Director
• Dror Berman, Director
• Kenneth Frazier, Director

Popular executive movements at Eikon Therapeutics

• Robert Huffines has joined the company as Director  (posted on December 4 2023).

Create your alert
to follow the executive moves at Eikon Therapeutics.

Eikon Therapeutics has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
• WindRose Health Investors has announced the acquisition of SubjectWell  (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Eikon Therapeutics

• Eikontx
• Eikontx

Social media about Eikon Therapeutics

• Eikon Therapeutics on Wikipedia, Google News & Yahoo Finance
• Eikon Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Roger Perlmutter

Call Eikon Therapeutics at +1 760...

View the org chart

Register to receive your alert

Report an error